Loading...

SILO SILO PHARMA INC Investments/Divestments 8-K Filing

SL P

SL

SILO PHARMA INC

(SILO)

2023 8-K

Show Summary

Show Summary

Equity Offerings

Investor Presentation

Shareholder Update

Annual Meeting Results

Annual Meeting Postponed

Investor Presentation

Securities Purchase Agreement

License Agreement with Colu...

Agreement Amendment

Securities Purchase Agreement

Other Special Situation

Stock Repurchase Program Ex...

Pipeline Prioritization Ann...

Amendment to Stock Repurcha...

Stock Repurchase Program Ex...

Change of Incorporation State

Annual Meeting Approval

Stock Authorization Decrease

Annual Meeting of Stockholders

Patent Application

Extension of License Agreement

Patent Application

Patent Application Filing

Patent Issuance

Stock Repurchase Program

Patent Applications

External Links:

Silo Pharma, Inc. received notice of successful transmission to the USPTO regarding its patent applications for the use of peptides and psilocybin for anti-inflammatory therapeutics in the central nervous system.

AI Assistant

SILO PHARMA INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.